Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Iranian general populations’ and health care providers’ preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease.

< BACK TO ARCHIVE


2020 Nov 04


BMC Med Inform Decis Mak


http://www.ncbi.nlm.nih.gov/pubmed/33148227?dopt=Abstract


20


1

Iranian general populations’ and health care providers’ preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease.

Authors

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease.
Saadati H, Baradaran H R, Danaei G, Ostovar A, Hadaegh F, Janani L, Steyerberg EW, Khalili D
BMC Med Inform Decis Mak. 2020 Nov 04; 20(1):288.
PMID: 33148227.

Abstract

The use of statins for primary prevention of cardiovascular diseases is associated with different benefit and harm outcomes. The aime of this study is how important these outcomes are for people and what people's preferences are.
Read This Paper